Oakridge International Limited (U9O0.F)

EUR 0.03

(36.36%)

EBITDA Summary of Oakridge International Limited

Oakridge International Limited's latest annual EBITDA in 2024 was -630.05 Thousand AUD , down -200.91% from previous year.
Oakridge International Limited's latest quarterly EBITDA in 2024 Q4 was -236.1 Thousand EUR , down 0.0% from previous quarter.
Oakridge International Limited reported an annual EBITDA of -203.66 Thousand AUD in 2023, up 73.06% from previous year.
Oakridge International Limited reported an annual EBITDA of -471.24 Thousand AUD in 2022, down -166.83% from previous year.
Oakridge International Limited reported a quarterly EBITDA of -236.1 Thousand EUR for 2024 Q4, down 0.0% from previous quarter.
Oakridge International Limited reported a quarterly EBITDA of N/A for 2023 FY, up 73.06% from previous quarter.

Annual EBITDA Chart of Oakridge International Limited (2024 - 2007)

Historical Annual EBITDA of Oakridge International Limited (2024 - 2007)

Year	EBITDA	EBITDA Growth
2024	-630.05 Thousand AUD	-200.91%
2023	-203.66 Thousand AUD	73.06%
2022	-471.24 Thousand AUD	-166.83%
2021	684.41 Thousand AUD	1928.74%
2020	-45.08 Thousand AUD	0.0%
2019	-3.61 Million AUD	100.91%
2018	-7.98 Million AUD	17.96%
2017	-5.65 Million AUD	-293.12%
2016	-3.06 Million AUD	200.39%
2015	-2.91 Million AUD	-292.57%
2014	-743.64 Thousand AUD	79.38%
2013	-3.6 Million AUD	87.26%
2012	-28.31 Million AUD	-1423.47%
2011	-1.85 Million AUD	50.17%
2010	-3.73 Million AUD	-82.33%
2009	-2.04 Million AUD	-21.71%
2008	-1.68 Million AUD	-215.13%
2007	-533.47 Thousand AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-321.78 Thousand EUR	0.0%
2024 Q4	-236.1 Thousand EUR	0.0%
2023 FY	- AUD	73.06%
2023 Q4	-100.48 Thousand EUR	48.61%
2023 Q2	-195.54 Thousand EUR	-15.96%
2022 Q2	-236.54 Thousand EUR	-35.7%
2022 Q4	-168.63 Thousand EUR	28.71%
2022 FY	- AUD	-166.83%
2021 FY	- AUD	1928.74%
2021 Q4	-174.31 Thousand EUR	19.78%
2021 Q2	-217.29 Thousand EUR	-0.93%
2020 Q2	-639.49 Thousand EUR	20.29%
2020 Q4	-215.28 Thousand EUR	66.34%
2020 FY	- AUD	0.0%
2019 Q4	-802.25 Thousand EUR	0.0%
2019 FY	- AUD	100.91%
2018 FY	- AUD	17.96%
2017 FY	- AUD	-293.12%
2016 FY	- AUD	200.39%
2015 FY	- AUD	-292.57%
2014 FY	- AUD	79.38%
2013 FY	- AUD	87.26%
2012 FY	- AUD	-1423.47%
2011 FY	- AUD	50.17%
2010 FY	- AUD	-82.33%
2009 FY	- AUD	-21.71%
2008 FY	- AUD	-215.13%
2007 FY	- AUD	0.0%

Peer EBITDA Comparison of Oakridge International Limited

Name	EBITDA	EBITDA Difference
DocCheck AG	9.38 Million EUR	106.715%
CompuGroup Medical SE & Co. KGaA	215.84 Million EUR	100.292%
MeVis Medical Solutions AG	5.12 Million EUR	112.283%
Nexus AG	53.43 Million EUR	101.179%